• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑静脉窦血栓形成作为月经过多抗纤溶治疗的潜在危害。

Cerebral sinus thrombosis as a potential hazard of antifibrinolytic treatment in menorrhagia.

作者信息

Achiron A, Gornish M, Melamed E

机构信息

Department of Neurology, Beilinson Medical Center, Petach-Tiqva, Israel.

出版信息

Stroke. 1990 May;21(5):817-9. doi: 10.1161/01.str.21.5.817.

DOI:10.1161/01.str.21.5.817
PMID:2339463
Abstract

We describe a 42-year-old woman who developed superior sagittal and left transverse sinus thrombosis associated with prolonged epsilon-aminocaproic acid therapy for menorrhagia. This antifibrinolytic agent has been used in women with menorrhagia to promote clotting and reduce blood loss. Although increased risk of thromboembolic disease has been reported during treatment with epsilon-aminocaproic acid, cerebral sinus thrombosis has not been previously described. Careful use of epsilon-aminocaproic acid therapy is recommended.

摘要

我们描述了一名42岁女性,她因月经过多接受了长时间的氨甲环酸治疗,随后发生了上矢状窦和左侧横窦血栓形成。这种抗纤维蛋白溶解剂已被用于月经过多的女性,以促进凝血并减少失血。虽然已有报道称在使用氨甲环酸治疗期间血栓栓塞性疾病的风险增加,但此前尚未有脑窦血栓形成的描述。建议谨慎使用氨甲环酸治疗。

相似文献

1
Cerebral sinus thrombosis as a potential hazard of antifibrinolytic treatment in menorrhagia.脑静脉窦血栓形成作为月经过多抗纤溶治疗的潜在危害。
Stroke. 1990 May;21(5):817-9. doi: 10.1161/01.str.21.5.817.
2
Cerebral thrombosis associated with Amicar therapy.与氨基己酸治疗相关的脑血栓形成。
Radiology. 1979 Jun;131(3):687-9. doi: 10.1148/131.3.687.
3
Epsilon-aminocaproic acid (EACA).ε-氨基己酸(EACA)。
Semin Thromb Hemost. 1978 Summer;5(1):27-40. doi: 10.1055/s-0028-1087143.
4
The incidence of deep vein thrombosis in prostatectomised patients following the administration of the fibrinolytic inhibitor, aminocaproic acid (EACA).在接受纤维蛋白溶解抑制剂氨基己酸(EACA)治疗的前列腺切除术后患者中深静脉血栓形成的发生率。
Urol Res. 1976 Nov 10;4(3):129-31. doi: 10.1007/BF00257169.
5
Extensive thrombosis following central venous catheterization--a relationship to antifibrinolytic therapy?中心静脉置管后广泛血栓形成——与抗纤溶治疗有关吗?
S Afr Med J. 1983 May 21;63(21):797.
6
Recurrent subarachnoid hemorrhage associated with aminocaproic acid therapy and acute renal artery thrombosis. Case report.与氨基己酸治疗及急性肾动脉血栓形成相关的复发性蛛网膜下腔出血。病例报告。
J Neurosurg. 1979 Jul;51(1):94-7. doi: 10.3171/jns.1979.51.1.0094.
7
Quantitative determination of plasma fibrinolytic activity in patients with ruptured intracranial aneurysms who are receiving epsilon-aminocaproic acid: relationship of possible complications of therapy to the degree of fibrinolytic inhibition.接受ε-氨基己酸治疗的颅内动脉瘤破裂患者血浆纤溶活性的定量测定:治疗可能并发症与纤溶抑制程度的关系
Neurosurgery. 1984 Jan;14(1):57-63. doi: 10.1227/00006123-198401000-00012.
8
Acute renal failure due to high-grade obstruction following therapy with epsilon-aminocaproic acid.使用ε-氨基己酸治疗后因高度梗阻导致的急性肾衰竭。
Am J Kidney Dis. 1986 Dec;8(6):441-4. doi: 10.1016/s0272-6386(86)80172-x.
9
Treatment of menorrhagia with epsilon aminocaproic acid. A double blind investigation.用ε-氨基己酸治疗月经过多。一项双盲研究。
Acta Obstet Gynecol Scand. 1965;44(3):467-73. doi: 10.3109/00016346509155880.
10
Obstruction of solitary kidney due to epsilon-aminocaproic-acid-induced fibrin clot formation.ε-氨基己酸诱导纤维蛋白凝块形成导致孤立肾梗阻。
Urology. 1984 Jul;24(1):64-6. doi: 10.1016/0090-4295(84)90390-x.

引用本文的文献

1
Acute promyelocytic leukaemia and acquired alpha-2-plasmin inhibitor deficiency: a retrospective look at the use of epsilon-aminocaproic acid (Amicar) in 30 patients.急性早幼粒细胞白血病与获得性α-2-纤溶酶抑制剂缺乏症:对30例患者使用ε-氨基己酸(氨甲环酸)的回顾性研究
Hematol Oncol. 2008 Dec;26(4):241-6. doi: 10.1002/hon.867.
2
A benefit-risk review of systemic haemostatic agents: part 1: in major surgery.全身性止血剂的获益-风险评估:第1部分:在大手术中
Drug Saf. 2008;31(3):217-30. doi: 10.2165/00002018-200831030-00003.
3
Risk-benefit assessment of drugs used for the treatment of menstrual disorders.
Drug Saf. 1991 May-Jun;6(3):183-91. doi: 10.2165/00002018-199106030-00004.
4
Menorrhagia. Current drug treatment concepts.
Drugs. 1992 Feb;43(2):201-9. doi: 10.2165/00003495-199243020-00006.